PRDX1 and neoplasm: found that LAMP 2a contributes to tumor progression by degrading PRDX1 (peroxiredoxin 1) and CRTC1 (CREB-regulated transcriptional coactivator 1), which enhances tumor-associated macrophage activation (188).